Skip to Main Content

Paper Details

Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus.
J Med Chem
5
2020
EBV, Epstein-Barr virus, HCMV, HSV1, HSV2, Human Cytomegalovirus, ganciclovir, herpes simplex virus, human cytomegalovirus, infants, letermovir, luciferase, pp28
Author NameAffiliation
Noel SouthallNational Center for Advancing Translational Sciences (NCATS), National Institute of Health
Noel SouthallNational Center for Advancing Translational Sciences (NCATS), National Institute of Health
David J MeyersJohns Hopkins University School of Medicine
Marc FerrerNational Center for Advancing Translational Sciences (NCATS), National Institute of Health
  • 1 - 4

Datasets

Release 1.2